HCW Biologics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021
Market Capitalization	23	44	69	83
Market Cap Growth	25.22%	-35.84%	-17.13%	-
Enterprise Value	27	47	43	46
PE Ratio	-	-1.76	-4.61	-6.44
PS Ratio	20.17	78.64	26.56	-
PB Ratio	2.68	3.27	1.84	1.62
P/FCF Ratio	-2.21	-1.53	-3.32	-7.52
P/OCF Ratio	-2.80	-1.96	-6.61	-7.55
EV/Sales Ratio	23.56	83.48	16.64	-
EV/EBITDA Ratio	-2.56	-1.98	-3.06	-3.76
EV/EBIT Ratio	-2.46	-1.89	-2.91	-3.59
EV/FCF Ratio	-2.35	-1.63	-2.08	-4.19
Debt / Equity Ratio	0.95	0.47	0.17	-
Debt / EBITDA Ratio	-0.32	-0.27	-0.46	-
Debt / FCF Ratio	-0.29	-0.22	-0.31	-
Quick Ratio	0.39	0.59	10.99	15.87
Current Ratio	0.46	0.73	11.52	17.44
Asset Turnover	0.04	0.02	0.05	0
Interest Coverage	-143.47	-87.31	-116.64	-
Return on Equity (ROE)	-146.80%	-101.50%	-34.00%	-83.10%
Return on Assets (ROA)	-81.70%	-67.90%	-30.30%	-37.90%
Return on Capital (ROIC)	-163.68%	-130.11%	-34.40%	-26.11%
Earnings Yield	-116.81%	-56.72%	-21.69%	-15.52%
FCF Yield	-121.58%	-65.16%	-30.08%	-13.30%
Buyback Yield / Dilution	-3.73%	-0.30%	-90.84%	-296.07%
Total Shareholder Return	-3.73%	-0.30%	-90.84%	-296.07%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).